1. Advances in intravesical drug delivery systems to treat bladder cancer
   Oluwadamilola M. Kolawole et al, 2017, International Journal of Pharmaceutics CrossRef
2. Methylseleninic acid induces apoptosis of human bladder cancer cells through the ROS‐mediated mitochondrial pathway
   Yi Chen et al, 2023, Journal of Biochemical and Molecular Toxicology CrossRef
3. Sequential Intravesical Mitomycin plus Bacillus Calmette–Guérin for Non–Muscle-Invasive Urothelial Bladder Carcinoma: Translational and Phase I Clinical Trial
   Robert S. Svatek et al, 2015, Clinical Cancer Research CrossRef
4. Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model
   Koetsu Tamura et al, 2015, BMC Cancer CrossRef
5. Optimizing intravesical mitomycin C therapy in non-muscle-invasive bladder cancer
   Homayoun Zargar et al, 2014, Nature Reviews Urology CrossRef
6. Topical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model
   Shunta Hori et al, 2017, PLOS ONE CrossRef
7. Systematic Review and Cumulative Analysis of the Combination of Mitomycin C plus Bacillus Calmette-Guérin (BCG) for Non–Muscle-Invasive Bladder Cancer
   Tuo Deng et al, 2017, Scientific Reports CrossRef
8. Curcumin as Treatment for Bladder Cancer: A Preclinical Study of Cyclodextrin-Curcumin Complex and BCG as Intravesical Treatment in an Orthotopic Bladder Cancer Rat Model
   J. Falke et al, 2018, BioMed Research International CrossRef
9. Nonpathogenic Mycobacterium brumae Inhibits Bladder Cancer Growth In Vitro, Ex Vivo, and In Vivo
   Estela Noguera-Ortega et al, 2016, European Urology Focus CrossRef